EUVIMEDEUVIMED entdecken
Crossref

The Role of Monounsaturated and Polyunsaturated Fatty Acids: Oleic and Linoleic in Type 2 Diabetes Management

Adams Olalekan Omoaghe, Tony A Ezike, Mailabari Y Hussaini, Nnamdi Ejieh, Olusoji A Oyesola, Samuel Kehinde Olaniyi

Biomedical Research and Therapy · 30.06.2026 · 13 (06) · 8724-8738

DOI: 10.15419/bmrat.v13i6.1079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Research and Therapy, online erschienen am 30.06.2026. Verfasst von Adams Olalekan Omoaghe und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dietary monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs)—particularly oleic acid (OA) and linoleic acid (LA)—are increasingly recognized as critical modulators of metabolic health and disease prevention. A growing body of evidence from clinical trials and experimental studies indicates that diets enriched in these unsaturated fats can improve insulin sensitivity, reduce systemic inflammation, and favorably alter lipid profiles compared to diets high in saturated fats. However, a limited number of studies report contradictory findings regarding the role of linoleic acid, particularly concerning lipid modulation and inflammation. Mechanistically, oleic and linoleic acids enhance insulin signaling through the activation of the PI3K/Akt/GLUT4 pathway, thereby promoting glucose uptake, while simultaneously suppressing pro-inflammatory cascades such as NF-κB and JNK. These dual actions highlight their potential efficacy in mitigating metabolic dysfunction in type 2 diabetes mellitus (T2DM). Despite consistent findings supporting their beneficial effects on glycemic control, debate persists regarding optimal intake levels, dose–response relationships, and long-term outcomes. This review synthesizes current knowledge, outlines dietary sources and intake guidelines, and identifies critical gaps in the research. Overall, oleic and linoleic acids demonstrate significant metabolic and anti-inflammatory benefits, positioning them as promising dietary components for T2DM management. However, standardized study designs and longitudinal investigations are required to clarify their translational relevance and establish evidence-based recommendations for clinical practice.

Zitieren

APA

Omoaghe, A. O., Ezike, T. A., Hussaini, M. Y., Ejieh, N., Oyesola, O. A., & Olaniyi, S. K. (2026). The Role of Monounsaturated and Polyunsaturated Fatty Acids: Oleic and Linoleic in Type 2 Diabetes Management. Biomedical Research and Therapy, 13(06), 8724-8738. https://doi.org/10.15419/bmrat.v13i6.1079

Vancouver

Omoaghe AO, Ezike TA, Hussaini MY, Ejieh N, Oyesola OA, Olaniyi SK. The Role of Monounsaturated and Polyunsaturated Fatty Acids: Oleic and Linoleic in Type 2 Diabetes Management. Biomedical Research and Therapy. 2026;13(06):8724-8738. doi:10.15419/bmrat.v13i6.1079

BibTeX
@article{Omoaghe2026,
  author = {Omoaghe, Adams Olalekan and Ezike, Tony A and Hussaini, Mailabari Y and Ejieh, Nnamdi and Oyesola, Olusoji A and Olaniyi, Samuel Kehinde},
  title = {The Role of Monounsaturated and Polyunsaturated Fatty Acids: Oleic and Linoleic in Type 2 Diabetes Management},
  journal = {Biomedical Research and Therapy},
  year = {2026},
  volume = {13},
  number = {06},
  pages = {8724--8738},
  doi = {10.15419/bmrat.v13i6.1079}
}
Kostenlos starten →